Chronic Headache Education and Self-Management Study (CHESS): a process evaluation
BMC Neurology volume 23, Article number: 8 (2023)
The Chronic Headache Education and Self-Management Study (CHESS) multicentre randomised trial evaluated the impact a group education and self-management support intervention with a best usual care plus relaxation control for people living with chronic headache disorders (tension type headaches or chronic migraine, with or without medication overuse headache). Here we report the process evaluation exploring potential explanations for the lack of positive effects from the CHESS intervention.
The CHESS trial included 736 (380 intervention: 356 control) people across the Midlands and London UK. We used a mixed methods approach. Our extensive process evaluation looked at context, reach, recruitment, dose delivered, dose received, fidelity and experiences of participating in the trial, and included participants and trial staff. We also looked for evidence in our qualitative data to investigate whether the original causal assumptions underpinning the intervention were realised.
The CHESS trial reached out to a large diverse population and recruited a representative sample. Few people with chronic tension type headaches without migraine were identified and recruited. The expected ‘dose‘of the intervention was delivered to participants and intervention fidelity was high. Attendance (“dose received”) fell below expectation, although 261/380 (69%) received at least at least the pre-identified minimum dose. Intervention participants generally enjoyed being in the groups but there was little evidence to support the causal assumptions underpinning the intervention were realised.
From a process evaluation perspective despite our extensive data collection and analysis, we do not have a clear understanding of why the trial outcome was negative as the intervention was delivered as planned. However, the lack of evidence that the intervention causal assumptions brought about the planned behaviour change may provide some insight. Our data suggests only modest changes in managing headache behaviours and some disparity in how participants engaged with components of the intervention within the timeframe of the study. Moving forwards, we need a better understanding of how those who live with chronic headache can be helped to manage this disabling condition more effectively over time.
The Chronic Headache Education and Self-Management Study (CHESS) was a multicentre randomised controlled trial comparing a group education and self-management intervention with a best usual care plus relaxation control for participants living with chronic tension type headaches, chronic migraine with or without medication overuse headache . It was a large, adequately powered, trial exploring the effect of the self-management intervention on the adverse impact of headache (social functioning, role functioning, vitality, cognitive functioning, psychological distress and pain). No detectable effect was found for the intervention on headache related quality of life at 12 months. This was measured with HIT-6 (Headache Impact Test) - a measure of the adverse impact of headache on social functioning, role functioning, vitality, cognitive functioning, and psychological distress. Among the predefined secondary outcomes, self-efficacy was improved in the self-management group at four and 12-months but there were no observable effects on headache days and severity, anxiety or depression. (Ref -Monograph and main paper).
Evaluation of the principal processes of a complex study helps to explain how an intervention could be optimised or why it may have failed [2,3,4]. There is now a growing body of published process evaluations that help to put trial results into context [5,6,7,8,9]. We conducted an extensive process evaluation (PE) alongside the CHESS trial using a mixed methods design collecting data on: context, reach, recruitment, dose-delivered, dose received, fidelity, and experiences of involvement in the trial . In this paper, we report this process evaluation and explore why the intervention failed to achieve a detectable clinical effect [11, 12].
The CHESS randomised controlled trial
This was undertaken between 2017 and 2020 in two areas of the UK (The Midlands and Greater London). We published our intervention development , feasibility study  and protocols for the trial  and process evaluation . The latter includes the causal assumptions of the intervention. Participants were primarily recruited from 164 general practices following a search of electronic clinical records that was wide in scope as chronic headache was poorly coded. For the trial there were 736 randomised participants with chronic headache, the primary analysis was on the 727 participants with migraine. For this evaluation we include all 736 participants. The intervention used a cognitive behavioural approach including behaviour change techniques aimed at helping participants manage their headaches better. Following informed consent, but prior to randomisation, participants had a consultation with a CHESS trained nurse to classify their headache . All participants and their GPs were informed of the classification of their headache. Figure 1, below, outlines the participant pathway through the CHESS trial and the basic components of the interventions.
The aims, objectives and methods used in this mixed-methods process evaluation are published in a protocol paper . To aid the reader we paraphrase/briefly summarise these below.
Aims and objectives
The aim of the process evaluation was to aid in the understanding of the results of trial outcome.
Our specific objectives were look at implementation processes, i.e., recruitment, reach, dose delivered, dose received, delivery of the intervention and acceptability/use of the intervention in practice and fidelity. In addition, carry out qualitative work around experiences with participants and the CHESS research team.
The process evaluation was guided by the MRC framework and included key components of process evaluation proposed by Steckler and Linnan [3, 4]. Table 1 shows the sources and types of data for each component of the evaluation.
Patient and public involvement
The CHESS reference group of 47 lay members, provided advice throughout the study . They were invited to a virtual meeting held via MS TEAMS to discuss the process evaluation results.
Data collection and primary analysis
We extracted relevant data from publicly available records and trial specific case report forms.
We distributed feedback forms to:
participants who attended group sessions asking them about the venues, facilitators and sessions, and
participating GP practices about their experiences of being in the trial – this was discontinued when the COVID 19 pandemic started to avoid burdening practices.
We entered quantitative data onto the study database and analysed using descriptive statistics. We took a random 3% sample of expression of interest forms from people who chose not to enter the trial and categorised reasons given. We assessed dose received based on the a priori definition of adherence for the trial: partial = day one plus one-to-one session, full = two sessions plus one-to-one.
We assessed fidelity of eight components of the intervention (see Table 4) from audio recordings of group sessions using an approach used in a previous study . We took a random sample of three of these components from each group (see Supplementary file 1, Tables S1 – S3 & Fig. S1, for further detail). One researcher (VN or DE) listened to these and rated adherence (whether the intervention was delivered as directed in the facilitators’ manual) and competence (a subjective assessment of facilitation) . We assessed interrater reliability through DE and VN independently rating an 11% sample and comparing results. We took a random 10% sample (n = 27) of the case report forms completed as part of the one-to-one sessions and assessed whether the proforma for the session was fully completed.
We interviewed participants from both arms of the trial at four and 12-months post randomisation. Recruitment to the process evaluation is detailed in the process evaluation protocol. All participants provided informed consent to participant in the trial and a purposive sample of these who, at the time of consent, agreed that they could be contacted to consider involvement in the process evaluation interview study were informed and consented to this . We sampled for diversity of practice context and type of headache continuing until we achieved data saturation from participants in both trial arms. In the four-month interviews we explored experience of intervention and asked intervention participants about each of the sessions from the two days and their experience of the one-to-one that followed this. In the 12 month interviews we explored impact on headache management of the intervention. Interviews were mostly face-to-face at four-months and by telephone at 12-months. All interviews were audio recorded with consent. Interviews were transcribed verbatim and identifying data removed prior to analysis using the framework method .
On completion of the trial, we held focus groups with the nurses and allied health professionals (AHP) who delivered the intervention. These consisted of two parts: 1) nurses and AHP facilitators reflected on the training they received and their experiences of delivering the intervention; 2) nurse facilitators reflected on the nurse specific training they received and delivering the nurse one-to-one sessions. We analysed thematically.
We reported our full analysis in detail, online, prior to trial results becoming available . In this paper, we present the results that provide insight into what participants received from the intervention and its impact. We report analysis supported by quotes labelled with participant ID number (e.g. 14).
Post-trial result analysis
After the trial results were available, we reinterrogated our analysed data from the four-month interviews on specific intervention components to identify whether any changes intervention participants attributed to intervention components matched the causal assumptions used in intervention design (See Supplementary file 2, Fig. S4 & ). DE, ST, and FG independently reviewed the analysis results and compared them with all six of the causal assumptions, then compared results, discussing discrepancies to achieve consensus.
Context and reach
We recruited from 164 general practices, with a median list size of 8979 (IQR 5760 to 11,986) including urban and rural locations (see also Supplementary file 3, Table S2). We included practices based in all ten deciles of the Index of Multiple Deprivation, median 5 (IQR 2 to 8). People from minority ethnic groups were over-represented in our practices; 27% (SD 23.4) compared to 14% in England and Wales in the 2011 census. Overall, 18% of participants recruited came from minority ethnic groups.
We approached 31,020 people, from the 164 practices representing around 2% of the practices’ population. Of these 2178 (7%) expressed an interest in the study (See Table 2). We randomised 3% 736 (380 intervention: 356 control) people into the CHESS trial. In our 3% sample of responses from people saying they were not interested in joining the trial (n = 85), the main categories of reason given were:
their headaches were not bad enough to make joining the group worthwhile
attending the headache self-management programme would take up too much of their time.
We successfully delivered 42 of 43 of the two-day group sessions in a variety of venues close to our recruiting practices (one session towards the end of the trial was cancelled due to the small number of participants who were incorporated into another group).
Of those randomised to the self-management intervention 288/380 (76%) attended at least one day. Of the 288, 227 (79%) attended both days and 261 (91%) took part in the one-to-one classification and advice session. Partial and full adherence was achieved by 261 (69%) and 57% (217/380) respectively. The median number of people attending on day one was 6.5 (IQR 5 to 9). Reasons for absences when provided included migraines, feeling unwell, work and family commitments.
We analysed recordings from 33 of the 42 groups, analysing 90 of the 99 sessions. Reasons for missing data included technical issues and facilitators forgetting to switch on recorders. Interrater reliability was 80% for adherence scores and 90% for competence scores.
The overall adherence score was 83% (IQR 67 to 100%) with several components achieving 100%. The two components achieving the lowest scores were ‘Unhelpful thinking patterns and finding alternatives’ 75% (IQR 72, 87%) and ‘managing setbacks’ 63% (IQR 58, 77%) (See Table 4).
The overall competence score was 70% (IQR 50 to 90%) but varied across components of the intervention. The highest competence score was for delivering ‘Acceptance of chronic headaches’ (90% (IQR 65 to 95%)) and the lowest was for ‘Impact of thoughts, and mood and emotion on headaches’ and ‘communicating better with health professionals’ (both scored 60% (IQRs 60 to 80% and 50 to 80%, respectively)) (See Table 3).
Fidelity check of Nurse-led one-to-one sessions
Proformas were all fully completed as required by the trial protocol .
Participants’ experiences of CHESS intervention
The interview sample is summarised in Table 4.
The following sections represent summaries of the full dataset which is available and where appropriate provides exemplar quotations .
Participants’ experiences of the group sessions
We identified the following five themes:
Discussion and sharing (being able to talk about headaches and share tips)
Shared experience of headache
Comparing with others (with some noting they were not as bad as others which made them feel better)
Feeling less isolated (realisation that they were not the only person who has to live with chronic headache)
Personal relevance (whilst most liked the groups some felt they were not relevant to them)
Participants comments on the group venue
Only ten participants commented on the venue in summary comments fell into the following categories:
The venue was fine
Issues related to personal comfort (e.g. heating, ventilation, lighting, external noise, and cramped space)
Issues specific to the venue (e.g. car parking, and poor signage)
Fourteen participants commented on how the facilitators delivered the course. The majority felt the groups were well run and were positive about the course delivery.
… the two people that were running it were great and they were very accommodating for us because if we went off track, they were happy to let us just explore what … we were talking about…31
Some commented on the relaxed nature of the groups.
… the ladies who lead the course were very good… I think we all felt very relaxed and easy… you know easy to chat…27
Three participants wanted more expert input into the group one commenting that the facilitators were not experts in headache. Three felt the pace was slow, two felt they did not get along with one of their facilitators and two felt that one of their facilitators had delivered some sessions poorly.
… the way it was executed by the person who was doing the facilitation was a bit muddled up so we didn’t fully understand what we were supposed to be doing… and then she did spend a whole couple of minutes literally reading… through the slides 25
Table 5a and b summarise responses of participants when asked about the specific intervention sessions. Overall, the sessions were acceptable, but some sessions were liked more than others and some sessions were felt to be irrelevant for some people.
Nurse led one-to-one sessions
Participants generally welcomed these one-to-one sessions. They liked being able to talk about their headaches with some who would listen. Headache classifications that were provided during these sessions were appreciated by most, but they also brought about a confusion, misunderstandings, and some disbelief in the classifications given. There was little or no evidence that goals had been set or achieved by participants.
Liked about headache diaries:
Able to monitor changes
Reassuring (especially if seeing improvements)
Helped identify triggers or patterns (or none)
A good aid when talking to the GP about their headaches
Disliked about headache diaries:
Being reminded about their condition
Difficult to complete regularly
Paper would prefer an App
Some noted that they felt they didn’t need this additional support, so they did not use them.
Others commented on what they liked about the telephone support.
Useful to reflect on how they were doing
Appreciated the additional support
Changes attributed to participating in the intervention
Fifteen group intervention interview participants contributed to this data from the 12-month interviews. We identified seven themes (see Table 6). Participants often gave responses in multiple themes (See Supplementary file 4, Table S3 for more details).
Participants’ experiences of control intervention
Among the nine control intervention participants interviewed, several found the pre-recorded guided relaxation session useful and used it regularly. Others did not find time in the day to devote time to relaxation or found the CD format inconvenient. In terms of the information provided by the study team, four control participants could not recall getting the information. Of the rest: One noted that the information was nothing new to them but then said that they did like the information about medications. Another noted that the information provided made them think about the triggers for their headaches. One participant commented that it made them aware of medication overuse headaches and as a result was careful with taking over the counter medications, also commenting that the information generally was useful. The final participant appreciated the information provided and being part of the study saying that the study “validated their headaches…”.
Facilitator experiences explored in focus groups
Twelve nurse facilitators and four allied health professional facilitators participated. The facilitators were generally happy with their training. They noted that a considerable amount of unplanned preparation time was needed before each session. There were sometimes long delays between training and session delivery and refresher training would have been beneficial. Facilitators found some sessions more challenging to deliver, notably: Session 4. Acceptance, Session 5 Impact of thoughts mood and emotions on headaches, Session 14. Mindfulness and relaxation for headaches, Session 15. Medication management, and Session 18. Managing setbacks.
Nurse facilitators found their specific training excellent, although more role play might have been beneficial. They found the CHESS manual very useful. The one-to-one sessions required more time than planned with many participants divulging much personal information. The nurse facilitators suggested that some debriefing would have been helpful. They found MOH was a difficult topic although they felt that some participants came to a realisation of its relevance. They noted that most participants reported cutting down their medication gradually with good results .
Feedback forms from intervention participants
The feedback form was completed by 117 participants at the end of the two-day group session. In general feedback was positive. Most valued was meeting and sharing with others. Least valued included the mindfulness and relaxation sessions (See Supplementary file 5, Table S4 for more details).
General practitioner feedback
We collected data from 25/64 practices. Responses to the three questions were:
What were your experiences of treating patients with chronic headache within the CHESS trial? 12 positive, 10 neutral, 0 negative, 3 no response
To what extent, if at all, has the CHESS trial changed your approach to treating chronic headache? 11 positive, 12 neutral, 0 negative, 4 no response
How would you describe your practice’s involvement in the CHESS trial, and would you be happy to be involved in similar trials in the future? 23 positive, 1 neutral, 0 negative, 1 no response
CHESS reference group discussion
Ten lay members attended the group discussion. Whilst they were disappointed generally with the results, they were also not that surprised. Noting that whilst this study tried a novel approach to the treatment of chronic headache, they felt that the results implied it was clearly not enough. They felt that chronic headache is under researched, a ‘hidden’ condition, which is often misunderstood and a major cause of disability and time off work, impacting on all aspects of life. The group noted that chronic headaches should be seen as a long-term condition which needs coordinated long term medical review, support, signposting to appropriate clinicians, information and services which may be of benefit. Future research will be important to explore the most useful avenues. The group felt that the results of this study should be presented in a way that gives clinicians and the public an understanding that chronic headache is a complex condition which should be taken seriously and that there is further work to be done.
We found little evidence that the changes that intervention participants attributed to intervention components matched the causal assumptions of the intervention design. For three components where there was evidence, we found there was an equal about of contrary evidence. See Table 7.
The CHESS intervention was delivered as planned with good levels of fidelity consistent with similar interventions . Over two thirds of participants received at least the planned minimum dose, consistent with other chronic disease self-management studies .
The opportunity to meet and have discussions with others who had a similar condition was valued by almost every study participant interviewed. Intervention group sessions were perceived as informative, but few people reported making changes to how they managed their headaches because of specific content. Most study participants had previous experience of keeping a headache diary. Although most participants valued the opportunity to discuss their medication in the one-to-one session with a nurse, only a few went on to discuss their medication with their GPs. Few participants interviewed for the process evaluation spoke of goal setting and none reported having achieved their goals. Twelve months after the intervention, participants reported little change to their headache management. There was little evidence to suggest that the causal assumptions for our intervention were realised within the time frame of our study.
Chronic headache is a condition that becomes embedded in all aspects of life. Our own systematic review completed in the early stages of this study, found that headache is a driver of behaviour, affects people’s relationships and is an ever present ‘spectre’ over their lives . This is echoed in more recent studies. A survey from Norway indicates that living with a chronic headache condition is associated with high levels of disability and considerable negative consequences for daily living . A US survey which included over a 1000 people with chronic migraine demonstrates the negative impacts that the condition has on sufferers including relationships, careers, finances, achievements, and overall health . An interview study from Spain found pain becomes the main focus of life and strongly impacts work and family . Our intervention was insufficient to prompt enough change in the way our participants managed their headaches and their lives to bring about a detectable effect for the intervention on headache related quality of life at 12 months. There is emerging evidence that suggests why this might be. An interview study exploring goal management in chronic headache demonstrates the complexities of goal management, the effort involved and that this can be a prolonged process sometimes involving major life changes such as changing work or avoiding expanding family size . Some of our participants reported modest goal setting such as monitoring fluid intake and improving sleep hygiene with a few considering or making major changes to their life such as their work within the time frame of our study. A qualitative study of people with chronic migraine and MOH explores the difference between those who frequently relapse after structured withdrawal for MOH and those who less frequently relapse. The former tend to attribute headache to uncontrollable factors, are resigned to their headaches and use passive coping strategies . This may help explain the range of responses to the component of our intervention on MOH. Studies such as these that explore the complexities of responses to components of our intervention may help us understand how to personalise interventions both in terms of content and duration. Such interventions may benefit from a multidisciplinary approach .
Strengths and weaknesses of the evaluation
Our process evaluation was extensive and followed a published protocol. Our assessment of the fidelity of the intervention was comprehensive. The interview sample may not be large enough to capture the diversity of ways participants responded to the intervention. GP feedback was limited due to the COVID pandemic. Evaluation of the one-to-one sessions was limited to clinical record forms. Nearly one third of those in the intervention arm did not attend enough to achieve our definition of “partial adherence”, this could, potentially, have diluted the effects of the intervention. Finally, whilst we approached a large population the trial failed to identify and recruit those with TTH without co-existent migraine and as a result was predominantly those with migraine.
Our intervention for chronic headache was delivered as planned and received by two thirds of participants. However, within the time frame of the study, there were only modest changes in how participants managed their headaches. The variation in how people responded to the components of the intervention suggests we need more understanding of how and why people respond as they do.
Availability of data and materials
Much of the data generated or analysed during this study are included in this published article [and its additional information files and published work]. Reasonable requests for the datasets used and/or analysed during the current study can be requested via the corresponding author.
Chronic Headache Education and Self-Management Study
Medication overuse headache
Tension type headache
National Health Service
Patient and public involvement
- MS TEAMS:
Microsoft Teams software
NIHR. Chronic Headache Education and Self-management Study (CHESS). In. Southampton: Department of Health; 2015.
Baranowski T, Stables G. Process evaluations of the 5-a-day projects. Health Educ Behav. 2000;27(2):157–66.
Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258.
Steckler A, Linnan L. Process Evaluation for Public health Interventions and research. San Fransisco: Jossey-Bass; 2002.
Demment MM, Graham ML, Olson CM. How an Online Intervention to Prevent Excessive Gestational Weight Gain Is Used and by Whom: A Randomized Controlled Process Evaluation. J Med Internet Res. 2014;16(8):1–1.
Ellard DR, Taylor SJ, Parsons S, Thorogood M. The OPERA trial: a protocol for the process evaluation of a randomised trial of an exercise intervention for older people in residential and nursing accommodation. Trials. 2011;12:28.
Gotlib Conn L, McKenzie M, Pearsall EA, McLeod RS. Successful implementation of an enhanced recovery after surgery programme for elective colorectal surgery: a process evaluation of champions' experiences. Implement Sci. 2015;10:99.
Oakley A, Strange V, Stephenson J, Forrest S, Monteiro H. Evaluating Processes:A Case Study of a Randomized Controlled Trial of Sex Education. Evaluation. 2004;10(4):440–62.
Partridge SR, Allman-Farinelli M, McGeechan K, Balestracci K, Wong ATY, Hebden L, et al. Process evaluation of TXT2BFiT: a multi-component mHealth randomised controlled trial to prevent weight gain in young adults. The International Journal of Behavioral Nutrition and Physical Activity. 2016;13:7.
Nichols VP, Ellard DR, Griffiths FE, Underwood M, Taylor SJ, Patel S. The CHESS trial: protocol for the process evaluation of a randomised trial of an education and self-management intervention for people with chronic headache. Trials. 2019;20(1):323.
Underwood M, Achana F, Carnes D, Eldridge S, Ellard DR, Griffiths F, Haywood K, Hee SW, Higgins H, Mistry D, Mistry H. A Supportive Self-Management Program for People with Chronic Headaches and Migraine: A Randomized Controlled Trial and Economic Evaluation. Neurology. 2022;16:10.1212/WNL.0000000000201518. https://doi.org/10.1212/WNL.0000000000201518. Epub ahead of print. PMID: 36526428.
Underwood M, Achana F, Carnes D, Eldridge S, Ellard DR, Griffiths F, Haywood K, Hee SW, Higgins H, Mistry D, et al. Chronic Headache Education and Self-management Study (CHESS): Feasibility study and a randomised controlled trial with health economic and process evaluations. Programme Grants Appl Res, In Press. PG-1212-20018.
Patel S, Potter R, Matharu M, Carnes D, Taylor SJC, Nichols V, et al. team C: Development of an education and self-management intervention for chronic headache - CHESS trial (Chronic Headache Education and Self-management Study). J Headache Pain. 2019;20(1):28.
White K, Potter R, Patel S, Nichols VP, Haywood KL, Hee SW, et al. Chronic Headache Education and Self-management Study (CHESS) - a mixed method feasibility study to inform the design of a randomised controlled trial. BMC Med Res Methodol. 2019;19(1):30.
Patel S, Achana F, Carnes D, Eldridge S, Ellard DR, Griffiths F, et al. Usual care and a self-management support programme versus usual care and a relaxation programme for people living with chronic headache disorders: a randomised controlled trial protocol (CHESS). BMJ Open. 2020;10(4):e033520.
Nichols V, Pearce G, Ellard DR, Evans S, Haywood K, Norman C, et al. Patient and public involvement in a UK National Institute for Health Research Programme Grant for Applied Research: experiences from the Chronic Headache Education and Self-management Study (CHESS). Prim Health Care Res Dev. 2021;22:e72.
Mars T, Ellard D, Carnes D, Homer K, Underwood M, Taylor SJ. Fidelity in complex behaviour change interventions: a standardised approach to evaluate intervention integrity. BMJ Open. 2013;3(11):e003555.
Ritchie J, Spencer L. Qualitative data analysis for applied policy research. The qualitative researcher’s companion. 2002;2002(573):305–29.
CHESS Process Evaluation Results Report (Vers 1). [http://wrap.warwick.ac.uk/145633/]. Accessed 30 May 2022.
Oosterhaven J, Wittink H, Mollema J, Kruitwagen C, Deville W. Predictors of dropout in interdisciplinary chronic pain management programmes: A systematic review. J Rehabil Med. 2019;51(1):2–10.
Nichols VP, Ellard DR, Griffiths FE, Kamal A, Underwood M, Taylor SJ. The lived experience of chronic headache: a systematic review and synthesis of the qualitative literature. BMJ Open. 2017;7(12):e019929.
Kristoffersen ES, Lundqvist C, Russell MB. Illness perception in people with primary and secondary chronic headache in the general population. J Psychosom Res. 2019;116:83–92.
Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM, et al. Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache: The Journal of Head and Face. Pain. 2019;59(8):1286–99.
Palacios-Ceña D, Neira-Martín B, Silva-Hernández L, Mayo-Canalejo D, Florencio LL, Fernández-de-Las-Peñas C, et al. Living with chronic migraine: a qualitative study on female patients' perspectives from a specialised headache clinic in Spain. BMJ Open. 2017;7(8):e017851.
Ciere Y, Visser A, Jacobs B, Padberg M, Lebbink J, Sanderman R, et al. Living with chronic headache: a qualitative study exploring goal management in chronic headache. Disabil Rehabil. 2018;40(25):2998–3004.
Scaratti C, Covelli V, Guastafierro E, Leonardi M, Grazzi L, Rizzoli PB, et al. A qualitative study on patients with chronic migraine with medication overuse headache: Comparing frequent and non-frequent relapsers. Headache: The Journal of Head and Face. Pain. 2018;58(9):1373–88.
Sahai-Srivastava S, Sigman E, Uyeshiro Simon A, Cleary L, Ginoza L. Multidisciplinary team treatment approaches to chronic daily headaches. Headache: The Journal of Head and Face. Pain. 2017;57(9):1482–91.
The project was funded by the National Institute for Health Research Health Technology Assessment programme (project RP-PG-1212-20018). The sponsors of the study played no part in the preparation of this Article. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the National Institute for Health Research (NIHR), or the Department of Health.
We thank all of the participants and the facilitators for their time and participating in this process evaluation. We also thank our PPI partners who have been invaluable throughout.
The CHESS Study Team (Consortium)
David R Ellard, Vivien Nichols, Frances Griffiths, Martin Underwood, Stephanie JC Taylor, Felix Achana, Dawn Carnes, Sandra Eldridge, Kirstie Haywood, Siew Wan Hee, Helen Higgins, Dipesh Mistry, Hema Mistry, Sian Newton, MSc3, Ms Chloe Norman1, Ms Emma Padfield1, Dr Shilpa Patel, DHealthPsy1, Professor Stavros Petrou, PhD6, Professor Tamar Pincus, PhD7, Dr Rachel Potter, PhD1, Dr Harbinder Sandhu, DHealthPsy1, Mrs Kimberley Stewart1, Dr Manjit Matharu, PhD8
1. Warwick Clinical Trials Unit, University of Warwick, Coventry, UK
2. University Hospitals Coventry and Warwickshire, Clifford bridge road, Coventry, CV2 2DX, UK
3. Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK
4. Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry 4. Queen Mary University of London, London, UK
5. University College of Osteopathy,275 Borough High St, London, UK
6. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
7. Department of Psychology, Royal Holloway, University of London, London, UK
8. Headache Group, Institute of Neurology and The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
The trial and process evaluation were funded by a National Institute of Health Research (NIHR) programme grant. Project number RP-PG-1212-20018 https://www.journalslibrary.nihr.ac.uk/programmes/pgfar/RP-PG-1212-20018/#/.
Ethics approval and consent to participate
Ethics approval was granted for the trial and its process evaluation on the 17th February 2017 by North West - Greater Manchester East Research Ethics Committee (REC REF: 16/NW/0890).
The trial and its process evaluation were conducted in accordance with the Declaration of Helsinki and relevant data protection legislation. All participants gave their informed consent for inclusion before they participated in the trial and the process evaluation.
Trial participants were, during the process of being informed and consented to be on the trial, asked if they were willing to be potentially contacted to participate in the interview study. A purposive sample of these participants (who said yes) were invited and again provided informed consent for this aspect of the trial. The facilitator, nurses and trial team members who are included in this process evaluation did so voluntarily. All gave informed consent. All of those who participated in this process evaluation had the right to withdraw at any time.
Consent for publication
MU is chief investigator or co-investigator on multiple previous and current research grants from the UK National Institute for Health Research, Arthritis Research UK and is a co-investigator on grants funded by the Australian NHMRC and Norwegian MRC. He was an NIHR Senior Investigator until March 2021. He has received travel expenses for speaking at conferences from the professional organisations hosting the conferences. He is a director and shareholder of Clinvivo Ltd. that provides electronic data collection for health services research. He is part of an academic partnership with Serco Ltd., funded by the European Social Fund, related to return-to-work initiatives. He receives some salary support from University Hospitals Coventry and Warwickshire He is a co-investigator on three NIHR funded studies receiving additional support from Stryker Ltd. Until March 2020 he was an editor of the NIHR journal series, and a member of the NIHR Journal Editors Group, for which he received a fee.
FG reports grants from NIHR during the conduct of the study.
SJCT reports grants from HTA Improving the Wellbeing of people with Opioid Treated CHronic pain; I-WOTCH HTA 14/224/04, grants from NIHR PGfAR Competition 14 Stage 2 Chronic Headache Education and Self-management Study (CHESS) reference number: RP-PG-1212-20018, grants from NIHR Programme Grant Round 3: RP-PG-0707-10189 “Self-management for Chronic Pain” (COPERS) outside the submitted work.
DRE reports grants from NIHR during the conduct of the study and he receives some salary support from NIHR Research Capability Funding via University Hospitals Coventry and Warwickshire.
VN Report no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Group session intervention fidelity
CHESS Process evaluation logic model
Areas in the UK where CHESS groups were delivered
Changes attributed to participating in the intervention arm of CHESS reported after the 12 month questionnaire.
Participant feedback (forms completed after the 2-day sessions)
About this article
Cite this article
Ellard, D.R., Nichols, V.P., Griffiths, F.E. et al. Chronic Headache Education and Self-Management Study (CHESS): a process evaluation. BMC Neurol 23, 8 (2023). https://doi.org/10.1186/s12883-022-02792-1
- Process evaluation
- Chronic headache
- Behaviour change intervention
- Mixed methods